Neurologic manifestations of hypothyroidism

INTRODUCTION

Hypothyroidism is a common medical condition in the general population. Common systemic manifestations include fatigue, constipation, cold intolerance, weight gain, hair loss, dry skin, and hoarseness. A variety of central and peripheral nervous system manifestations are common in patients with hypothyroidism (table 1). In many cases, the neurologic manifestations occur in conjunction with the systemic features of the disease and may be noted only incidentally. However, symptoms and signs of neurologic dysfunction may be the presenting feature in some patients and can contribute significant disability. Most of these complications are partially or fully responsive to thyroid replacement.

This topic reviews the common neurologic manifestations of hypothyroidism. Other clinical manifestations of hypothyroidism are discussed separately. (See "Clinical manifestations of hypothyroidism".)

PERSISTENT AFFECTS OF CONGENITAL HYPOTHYROIDISM

Cretinism refers to the sequelae of hypothyroidism in the development of the fetus and/or young infant. Although the effects of postnatal hypothyroidism can be ameliorated by prompt treatment, the sequelae of gestational hypothyroidism, particularly in the first trimester, persist throughout life. A common cause of congenital hypothyroidism is maternal and infant iodine deficiency, which is still endemic in some parts of Europe and elsewhere in the world.

Neurologic sequelae include:

Mental retardation. The severity of cognitive impairments is associated with both the degree and duration of thyroid (or iodine) deficiency in utero and early life [1]. Severe deficiency in the first trimester of pregnancy in particular is associated with severe irreversible intellectual as well as motor impairment [2,3].

Even children exposed to mild degrees of iodine deficiency in gestation and those with postnatal congenital hypothyroidism that is promptly recognized at birth, are likely to have mild, often subclinical, neuropsychiatric deficits when compared with siblings and other control groups [4]. Studies suggest that in postnatal hypothyroidism, earlier administration of higher-dose thyroxine treatment is associated with less severe deficits [5]. (See "Treatment and prognosis of congenital hypothyroidism".)

                                     

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Sep 2014. | This topic last updated: Aug 4, 2014.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. Glinoer D, Delange F. The potential repercussions of maternal, fetal, and neonatal hypothyroxinemia on the progeny. Thyroid 2000; 10:871.
  2. Halpern JP, Boyages SC, Maberly GF, et al. The neurology of endemic cretinism. A study of two endemias. Brain 1991; 114 ( Pt 2):825.
  3. Cao XY, Jiang XM, Dou ZH, et al. Timing of vulnerability of the brain to iodine deficiency in endemic cretinism. N Engl J Med 1994; 331:1739.
  4. Lazarus JH. Thyroid hormone and intellectual development: a clinician's view. Thyroid 1999; 9:659.
  5. Oerbeck B, Sundet K, Kase BF, Heyerdahl S. Congenital hypothyroidism: no adverse effects of high dose thyroxine treatment on adult memory, attention, and behaviour. Arch Dis Child 2005; 90:132.
  6. Arii J, Tanabe Y, Makino M, et al. Children with irreversible brain damage associated with hypothyroidism and multiple intracranial calcifications. J Child Neurol 2002; 17:309.
  7. Ma T, Lian ZC, Qi SP, et al. Magnetic resonance imaging of brain and the neuromotor disorder in endemic cretinism. Ann Neurol 1993; 34:91.
  8. Hagberg B, Westphal O. Ataxic syndrome in congenital hypothyroidism. Acta Paediatr Scand 1970; 59:323.
  9. Wiebel J. Cerebellar-ataxic syndrome in children and adolescents with hypothyroidism under treatment. Acta Paediatr Scand 1976; 65:201.
  10. Gauchard GC, Deviterne D, Leheup B, Perrin PP. Effect of age at thyroid stimulating hormone normalization on postural control in children with congenital hypothyroidism. Dev Med Child Neurol 2004; 46:107.
  11. Nicholson JL, Altman J. The effects of early hypo- and hyperthyroidism on the development of rat cerebellar cortex. I. Cell proliferation and differentiation. Brain Res 1972; 44:13.
  12. Koibuchi N, Jingu H, Iwasaki T, Chin WW. Current perspectives on the role of thyroid hormone in growth and development of cerebellum. Cerebellum 2003; 2:279.
  13. Leigh H, Kramer SI. The psychiatric manifestations of endocrine disease. Adv Intern Med 1984; 29:413.
  14. Osterweil D, Syndulko K, Cohen SN, et al. Cognitive function in non-demented older adults with hypothyroidism. J Am Geriatr Soc 1992; 40:325.
  15. Haupt M, Kurz A. Reversibility of dementia in hypothyroidism. J Neurol 1993; 240:333.
  16. del Ser Quijano T, Delgado C, Martínez Espinosa S, Vázquez C. [Cognitive deficiency in mild hypothyroidism]. Neurologia 2000; 15:193.
  17. Miller KJ, Parsons TD, Whybrow PC, et al. Memory improvement with treatment of hypothyroidism. Int J Neurosci 2006; 116:895.
  18. Tunbridge WM, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977; 7:481.
  19. Bagchi N, Brown TR, Parish RF. Thyroid dysfunction in adults over age 55 years. A study in an urban US community. Arch Intern Med 1990; 150:785.
  20. Sawin CT, Chopra D, Azizi F, et al. The aging thyroid. Increased prevalence of elevated serum thyrotropin levels in the elderly. JAMA 1979; 242:247.
  21. Ganguli M, Burmeister LA, Seaberg EC, et al. Association between dementia and elevated TSH: a community-based study. Biol Psychiatry 1996; 40:714.
  22. Larson EB, Reifler BV, Sumi SM, et al. Diagnostic evaluation of 200 elderly outpatients with suspected dementia. J Gerontol 1985; 40:536.
  23. Löppönen MK, Isoaho RE, Räihä IJ, et al. Undiagnosed diseases in patients with dementia--a potential target group for intervention. Dement Geriatr Cogn Disord 2004; 18:321.
  24. Luboshitzky R, Oberman AS, Kaufman N, et al. Prevalence of cognitive dysfunction and hypothyroidism in an elderly community population. Isr J Med Sci 1996; 32:60.
  25. Lindeman RD, Schade DS, LaRue A, et al. Subclinical hypothyroidism in a biethnic, urban community. J Am Geriatr Soc 1999; 47:703.
  26. Volpato S, Guralnik JM, Fried LP, et al. Serum thyroxine level and cognitive decline in euthyroid older women. Neurology 2002; 58:1055.
  27. Prinz PN, Scanlan JM, Vitaliano PP, et al. Thyroid hormones: positive relationships with cognition in healthy, euthyroid older men. J Gerontol A Biol Sci Med Sci 1999; 54:M111.
  28. Stern RA, Davis JD, Rogers BL, et al. Preliminary study of the relationship between thyroid status and cognitive and neuropsychiatric functioning in euthyroid patients with Alzheimer dementia. Cogn Behav Neurol 2004; 17:219.
  29. Gussekloo J, van Exel E, de Craen AJ, et al. Thyroid status, disability and cognitive function, and survival in old age. JAMA 2004; 292:2591.
  30. Kalmijn S, Mehta KM, Pols HA, et al. Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clin Endocrinol (Oxf) 2000; 53:733.
  31. Lathe R. Hormones and the hippocampus. J Endocrinol 2001; 169:205.
  32. Small GW, Matsuyama SS, Komanduri R, et al. Thyroid disease in patients with dementia of the Alzheimer type. J Am Geriatr Soc 1985; 33:538.
  33. Yoshimasu F, Kokmen E, Hay ID, et al. The association between Alzheimer's disease and thyroid disease in Rochester, Minnesota. Neurology 1991; 41:1745.
  34. de Jong FJ, den Heijer T, Visser TJ, et al. Thyroid hormones, dementia, and atrophy of the medial temporal lobe. J Clin Endocrinol Metab 2006; 91:2569.
  35. van der Cammen TJ, Mattace-Raso F, van Harskamp F, de Jager MC. Lack of association between thyroid disorders and Alzheimer's disease in older persons: a cross-sectional observational study in a geriatric outpatient population. J Am Geriatr Soc 2003; 51:884.
  36. van Osch LA, Hogervorst E, Combrinck M, Smith AD. Low thyroid-stimulating hormone as an independent risk factor for Alzheimer disease. Neurology 2004; 62:1967.
  37. Sampaolo S, Campos-Barros A, Mazziotti G, et al. Increased cerebrospinal fluid levels of 3,3',5'-triiodothyronine in patients with Alzheimer's disease. J Clin Endocrinol Metab 2005; 90:198.
  38. Kinuya S, Michigishi T, Tonami N, et al. Reversible cerebral hypoperfusion observed with Tc-99m HMPAO SPECT in reversible dementia caused by hypothyroidism. Clin Nucl Med 1999; 24:666.
  39. Constant EL, de Volder AG, Ivanoiu A, et al. Cerebral blood flow and glucose metabolism in hypothyroidism: a positron emission tomography study. J Clin Endocrinol Metab 2001; 86:3864.
  40. Smith CD, Ain KB. Brain metabolism in hypothyroidism studied with 31P magnetic-resonance spectroscopy. Lancet 1995; 345:619.
  41. Sui L, Wang F, Li BM. Adult-onset hypothyroidism impairs paired-pulse facilitation and long-term potentiation of the rat dorsal hippocampo-medial prefrontal cortex pathway in vivo. Brain Res 2006; 1096:53.
  42. Constant EL, Adam S, Seron X, et al. Anxiety and depression, attention, and executive functions in hypothyroidism. J Int Neuropsychol Soc 2005; 11:535.
  43. Clarnette RM, Patterson CJ. Hypothyroidism: does treatment cure dementia? J Geriatr Psychiatry Neurol 1994; 7:23.
  44. Cunha UG. An investigation of dementia among elderly outpatients. Acta Psychiatr Scand 1990; 82:261.
  45. Wekking EM, Appelhof BC, Fliers E, et al. Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidism. Eur J Endocrinol 2005; 153:747.
  46. Davis JD, Stern RA, Flashman LA. Cognitive and neuropsychiatric aspects of subclinical hypothyroidism: significance in the elderly. Curr Psychiatry Rep 2003; 5:384.
  47. Bono G, Fancellu R, Blandini F, et al. Cognitive and affective status in mild hypothyroidism and interactions with L-thyroxine treatment. Acta Neurol Scand 2004; 110:59.
  48. Nyström E, Caidahl K, Fager G, et al. A double-blind cross-over 12-month study of L-thyroxine treatment of women with 'subclinical' hypothyroidism. Clin Endocrinol (Oxf) 1988; 29:63.
  49. Jaeschke R, Guyatt G, Gerstein H, et al. Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism? J Gen Intern Med 1996; 11:744.
  50. De-Fa Zhu, Brain 2006; 129:2923.
  51. Parle J, Roberts L, Wilson S, et al. A randomized controlled trial of the effect of thyroxine replacement on cognitive function in community-living elderly subjects with subclinical hypothyroidism: the Birmingham Elderly Thyroid study. J Clin Endocrinol Metab 2010; 95:3623.
  52. Knopman DS, Petersen RC, Cha RH, et al. Incidence and causes of nondegenerative nonvascular dementia: a population-based study. Arch Neurol 2006; 63:218.
  53. Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56:1143.
  54. Larson EB, Reifler BV, Sumi SM, et al. Diagnostic tests in the evaluation of dementia. A prospective study of 200 elderly outpatients. Arch Intern Med 1986; 146:1917.
  55. Munhoz RP, Teive HA, Troiano AR, et al. Parkinson's disease and thyroid dysfunction. Parkinsonism Relat Disord 2004; 10:381.
  56. Berger JR, Kelley RE. Thyroid function in Parkinson disease. Neurology 1981; 31:93.
  57. Johannessen AC, Boye A, Pakkenberg H. Thyroid function in patients with Parkinson's disease. Acta Neurol Scand 1987; 75:364.
  58. García-Moreno JM, Chacón-Peña J. Hypothyroidism and Parkinson's disease and the issue of diagnostic confusion. Mov Disord 2003; 18:1058.
  59. Wingert TD, Hershman JM. Sinemet and thyroid function in Parkinson disease. Neurology 1979; 29:1073.
  60. NICKEL SN, FRAME B. Neurologic manifestations of myxedema. Neurology 1958; 8:511.
  61. JELLINEK EH, KELLY RE. Cerebellar syndrome in myxoedema. Lancet 1960; 2:225.
  62. Sandyk R. Cerebellar dysfunction in hypothyroidism. S Afr Med J 1982; 62:468.
  63. Cremer GM, Goldstein NP, Paris J. Myxedema and ataxia. Neurology 1969; 19:37.
  64. Pinelli P, Pisano F, Miscio G. Ataxia in myxoedema: a neurophysiological reassessment. J Neurol 1990; 237:405.
  65. Quinn N, Barnard RO, Kelly RE. Cerebellar syndrome in myxoedema revisited: a published case with carcinomatosis and multiple system atrophy at necropsy. J Neurol Neurosurg Psychiatry 1992; 55:616.
  66. Chotmongkol V, Bhuripanyo P. Movement disorder in hypothyroidism: a case report. J Med Assoc Thai 1989; 72:288.
  67. van Dijk MA, Reitsma JB, Fischer JC, Sanders GT. Indications for requesting laboratory tests for concurrent diseases in patients with carpal tunnel syndrome: a systematic review. Clin Chem 2003; 49:1437.
  68. Duyff RF, Van den Bosch J, Laman DM, et al. Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study. J Neurol Neurosurg Psychiatry 2000; 68:750.
  69. Kececi H, Degirmenci Y. Hormone replacement therapy in hypothyroidism and nerve conduction study. Neurophysiol Clin 2006; 36:79.
  70. Atcheson SG, Ward JR, Lowe W. Concurrent medical disease in work-related carpal tunnel syndrome. Arch Intern Med 1998; 158:1506.
  71. Solomon DH, Katz JN, Bohn R, et al. Nonoccupational risk factors for carpal tunnel syndrome. J Gen Intern Med 1999; 14:310.
  72. Karpitskaya Y, Novak CB, Mackinnon SE. Prevalence of smoking, obesity, diabetes mellitus, and thyroid disease in patients with carpal tunnel syndrome. Ann Plast Surg 2002; 48:269.
  73. Cakir M, Samanci N, Balci N, Balci MK. Musculoskeletal manifestations in patients with thyroid disease. Clin Endocrinol (Oxf) 2003; 59:162.
  74. PURNELL DC, DALY DD, LIPSCOMB PR. Carpal-tunnel syndrome associated with myxedema. Arch Intern Med 1961; 108:751.
  75. Dyck PJ, Lambert EH. Polyneuropathy associated with hypothyroidism. J Neuropathol Exp Neurol 1970; 29:631.
  76. Chisholm JC Jr. Hypothyroidism: a rare cause of the bilateral carpal tunnel syndrome--a case report and a review of the literature. J Natl Med Assoc 1981; 73:1082.
  77. Wood KA, Jacoby RJ. Lithium induced hypothyroidism presenting with carpal tunnel syndrome. Br J Psychiatry 1986; 149:386.
  78. Palumbo CF, Szabo RM, Olmsted SL. The effects of hypothyroidism and thyroid replacement on the development of carpal tunnel syndrome. J Hand Surg Am 2000; 25:734.
  79. Beghi E, Delodovici ML, Bogliun G, et al. Hypothyroidism and polyneuropathy. J Neurol Neurosurg Psychiatry 1989; 52:1420.
  80. Laycock MA, Pascuzzi RM. The neuromuscular effects of hypothyroidism. Semin Neurol 1991; 11:288.
  81. Rao SN, Katiyar BC, Nair KR, Misra S. Neuromuscular status in hypothyroidism. Acta Neurol Scand 1980; 61:167.
  82. Pollard JD, McLeod JG, Honnibal TG, Verheijden MA. Hypothyroid polyneuropathy. Clinical, electrophysiological and nerve biopsy findings in two cases. J Neurol Sci 1982; 53:461.
  83. Nemni R, Bottacchi E, Fazio R, et al. Polyneuropathy in hypothyroidism: clinical, electrophysiological and morphological findings in four cases. J Neurol Neurosurg Psychiatry 1987; 50:1454.
  84. Shirabe T, Tawara S, Terao A, Araki S. Myxoedematous polyneuropathy: a light and electron microscopic study of the peripheral nerve and muscle. J Neurol Neurosurg Psychiatry 1975; 38:241.
  85. Sidenius P, Nagel P, Larsen JR, et al. Axonal transport of slow component a in sciatic nerves of hypo- and hyperthyroid rats. J Neurochem 1987; 49:1790.
  86. Misiunas A, Niepomniszcze H, Ravera B, et al. Peripheral neuropathy in subclinical hypothyroidism. Thyroid 1995; 5:283.
  87. Ørstavik K, Norheim I, Jørum E. Pain and small-fiber neuropathy in patients with hypothyroidism. Neurology 2006; 67:786.
  88. Magri F, Buonocore M, Oliviero A, et al. Intraepidermal nerve fiber density reduction as a marker of preclinical asymptomatic small-fiber sensory neuropathy in hypothyroid patients. Eur J Endocrinol 2010; 163:279.
  89. Dick DJ, Lane RJ, Nogues MA, Fawcett PR. Polyneuropathy in occult hypothyroidism. Postgrad Med J 1983; 59:518.
  90. Toscano A, Rodolico C, Benvenga S, et al. Multifocal motor neuropathy and asymptomatic Hashimoto's thyroiditis: first report of an association. Neuromuscul Disord 2002; 12:566.
  91. Polizzi A, Ruggieri M, Vecchio I, et al. Autoimmune thyroiditis and acquired demyelinating polyradiculoneuropathy. Clin Neurol Neurosurg 2001; 103:151.
  92. Kohli RS, Bleibel W, Bleibel H. Concurrent immune thrombocytopenic purpura and Guillain-Barre syndrome in a patient with Hashimoto's thyroiditis. Am J Hematol 2007; 82:307.
  93. Schwartz MS, Mackworth-Young CG, McKeran RO. The tarsal tunnel syndrome in hypothyroidism. J Neurol Neurosurg Psychiatry 1983; 46:440.
  94. Yamamoto K, Saito K, Takai T, et al. Visual field defects and pituitary enlargement in primary hypothyroidism. J Clin Endocrinol Metab 1983; 57:283.
  95. Khawaja NM, Taher BM, Barham ME, et al. Pituitary enlargement in patients with primary hypothyroidism. Endocr Pract 2006; 12:29.
  96. Anand VT, Mann SB, Dash RJ, Mehra YN. Auditory investigations in hypothyroidism. Acta Otolaryngol 1989; 108:83.
  97. Meyerhoff WL. Hypothyroidism and the ear: electrophysiological, morphological, and chemical considerations. Laryngoscope 1979; 89:1.
  98. Brenner M, Hoistad DL, Hain TC. Prevalence of thyroid dysfunction in patients with Ménière's disease. Arch Otolaryngol Head Neck Surg 2004; 130:226.
  99. Téllez-Zenteno JF, Cardenas G, Estañol B, et al. Associated conditions in myasthenia gravis: response to thymectomy. Eur J Neurol 2004; 11:767.
  100. Singh SK. Prevalence of migraine in hypothyroidism. J Assoc Physicians India 2002; 50:1455.
  101. Moreau T, Manceau E, Giroud-Baleydier F, et al. Headache in hypothyroidism. Prevalence and outcome under thyroid hormone therapy. Cephalalgia 1998; 18:687.
  102. Iwasaki Y, Kinoshita M, Ikeda K, et al. Thyroid function in patients with chronic headache. Int J Neurosci 1991; 57:263.
  103. Hagen K, Bjøro T, Zwart JA, et al. Low headache prevalence amongst women with high TSH values. Eur J Neurol 2001; 8:693.
  104. Amy JR. Tests of thyroid function in chronic headache patients. Headache 1987; 27:351.
  105. Larner AJ. Thyroid dysfunction and headache. J Headache Pain 2006; 7:51.